SAMJIN PHARMACEUTICAL CO.,LTD
Researches & develops drugs for cardiovascular, respiratory, and gastrointestinal disorders.
005500 | KO
Overview
Corporate Details
- ISIN(s):
- KR7005500004
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구
- Website:
- https://www.samjinpharm.co.kr/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Samjin Pharmaceutical Co., Ltd. is a Korean pharmaceutical company dedicated to the research, development, and manufacturing of treatments to improve human health. The company focuses on creating innovative therapies for diseases with high unmet medical needs, including cardiovascular, respiratory, and gastrointestinal disorders, with an ambition to become a global leader in the field. Through significant investment in R&D, Samjin has developed a diverse portfolio of both prescription and over-the-counter medications. Key products include the antiplatelet drug Plariss, the analgesic Geborin, and the hypercholesterolemia treatment Newstatin R. The company emphasizes securing technological competitiveness and building a robust pipeline of novel drugs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 126.6 KB | ||
| 2025-08-27 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-08-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 126.6 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | ||
| 2025-07-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 96.6 KB | ||
| 2025-07-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 96.6 KB | ||
| 2025-07-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.1 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-05-12 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식취득신탁계약해지결정)
|
Korean | 27.9 KB | ||
| 2025-05-12 00:00 |
Regulatory News Service
신탁계약해지결과보고서
|
Korean | 18.4 KB | ||
| 2025-03-21 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 25.7 KB | ||
| 2025-03-21 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.2 KB | ||
| 2025-03-21 00:00 |
Board/Management Information
대표이사(대표집행임원)변경(안내공시)
|
Korean | 5.7 KB | ||
| 2025-03-13 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 11.3 KB | ||
| 2025-03-13 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.4 MB |
Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SAMJIN PHARMACEUTICAL CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
